Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultradian subcutaneous hydrocortisone infusion in Addison's disease
2013-004189-33Phase 2Completed
- Sponsor
- Haukeland University Hospital
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of hydrocortisone in Addison's disease (2 arms), sponsored by Haukeland University Hospital. Primary endpoint: Effects of USHI versus CSHI on steroid metabolism and ultradian rhythmicity. Started Oct 2013; status: completed.
02
Drugs
hydrocortisone
03
Conditions
Addison's disease
Beyond the preview
Go deeper on 2013-004189-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004189-33.